Skip to content

Drug interactions

Loxapine + Oxybutynin transdermal

Severity: Moderate

Loxapine and Oxybutynin transdermal: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Loxapine has anticholinergic activity that may add to the antimuscarinic effects of transdermal oxybutynin, causing dry mouth, constipation, urinary retention, blurred vision and confusion. Older patients are especially susceptible to cognitive effects.

What this interaction means in plain words

Loxapine and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive antimuscarinic effects at peripheral and central muscarinic receptors.

What to do

Monitor for anticholinergic toxicity, including constipation, retention and confusion, and use the lowest effective doses. Consider a non-anticholinergic bladder agent in vulnerable patients.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Loxapine and Oxybutynin transdermal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Loxapine with Oxybutynin transdermal?

MediHelp rates the interaction as moderate. Loxapine and Oxybutynin transdermal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Loxapine has anticholinergic activity that may add to the antimuscarinic effects of transdermal oxybutynin, causing dry mouth, constipation, urinary retention, blurred vision and confusion. Older patients are especially susceptible to cognitive effects.

How serious is the interaction between Loxapine and Oxybutynin transdermal?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for anticholinergic toxicity, including constipation, retention and confusion, and use the lowest effective doses. Consider a non-anticholinergic bladder agent in vulnerable patients.

What other medicines interact with Loxapine?

MediHelp also lists interactions of Loxapine with, for example, Alfentanil, Alprazolam, Amisulpride. The full list is on the Loxapine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in